NeoGenomics, Inc.
Ticker
NEO
ISIN
US64049M209
Price
USD 9.65
Change Today
-0.32 / -3.21 %
Price 1 year ago
12.43 / -22.365 %
Market Capitalization
1,346,017,152.00
52 Week Low
9.65
52 Week High
12.50
200 Day Moving Average
11.34
50-day Moving Average
11.34
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Exchange
NCM
Earnings Per Share
-0.294
P/E Ratio
-
Debt/Equity Ratio
58.638
Beta
0.935339
Ebitda
-105,895,000.00
Ebitda Margins
-0.22
Enterprise to Ebitda
-13.99
Enterprise Value
1,481,897,472.00
Target Price
17.80
Estimated Price
-
Book Value
8.30
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
| Company | Name | Correlation |
|---|---|---|
| 7707.T | PRECISION SYSTEM SCIENCE CO | 0.05 |
| ACL.AX | AUCLINICAL FPO | 0.08 |
| ILMN | Illumina, Inc. | 0.09 |
| OPK | Opko Health, Inc. | 0.10 |
| HLS.AX | HEALIUS FPO | 0.21 |
| SHL.AX | SONIC HLTH FPO | 0.22 |
| IQV | IQVIA Holdings, Inc. | 0.27 |
| TMO | Thermo Fisher Scientific Inc | 0.28 |
| DHR | Danaher Corporation | 0.30 |
| A | Agilent Technologies, Inc. | 0.31 |
| SHC | Sotera Health Company | 0.41 |
| NTRA | Natera, Inc. | 0.45 |
| NVTA | Invitae Corporation | 0.47 |
| NEOG | Neogen Corporation | 0.57 |
| GTG.AX | GENE TECH FPO |
Similar companies
| Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
|---|---|---|---|---|---|---|---|---|---|
| 603259.SS | WUXI APPTEC CO LTD | Shanghai | China | CNY | SHH | 0.70 | 37.16 | 39716 | https://www.wuxiapptec.com |
| NVTA | Invitae Corporation | San Francisco | United States | USD | NYQ | 2.02 | -1.79 | 2900 | https://www.invitae.com |
| 300482.SZ | GUANGZHOU WONDFO B | Guangzhou | China | CNY | SHZ | 0.09 | 9.87 | 3411 | https://www.wondfo.com.cn |
| BNGO | Bionano Genomics, Inc. | San Diego | United States | USD | NCM | 2.26 | -4.31 | 299 | https://www.bionanogenomics.com |
| 603108.SS | SHANGHAI RUNDA MEDICAL TECHNOLO | Shanghai | China | CNY | SHH | 0.52 | 10.15 | 3214 | https://www.rundamedical.com |
| 300347.SZ | HANGZHOU TIGERMED | Hangzhou | China | CNY | SHZ | 0.82 | 50.10 | 8326 | https://www.tigermed.net |
| 300463.SZ | MACCURA BIOTECHNOL | Chengdu | China | CNY | SHZ | 0.45 | 9.05 | 2865 | https://www.maccura.com |
| APDN | Applied DNA Sciences, Inc. | Stony Brook | United States | USD | NCM | 1.31 | 0.05 | 78 | https://www.adnas.com |
| 300244.SZ | DIAN DIAGNOSTICS G | Hangzhou | China | CNY | SHZ | 0.31 | 7.74 | 11123 | https://www.dazd.cn |
| 300439.SZ | MEDICALSYSTEM BIOT | Ningbo | China | CNY | SHZ | 0.38 | 11.13 | https://www.nbmedicalsystem.com | |
| 603127.SS | JOINN LABORATORIES (CHINA) CO L | Beijing | China | CNY | SHH | 0.40 | 78.23 | 2140 | https://www.joinn-lab.com |
| 300406.SZ | BEIJING STRONG BIO | Beijing | China | CNY | SHZ | 0.64 | 20.66 | https://www.bsbe.com.cn | |
| OPK | Opko Health, Inc. | Miami | United States | USD | NMS | 1.88 | -56.28 | 5767 | https://www.opko.com |
| 603882.SS | GUANGZHOU KINGMED DIAGNOSTICS G | Guangzhou | China | CNY | SHH | 0.53 | 8.93 | 12371 | https://www.kingmed.com.cn |
| SQL | SeqLL Inc. | Billerica | United States | USD | NCM | -0.70 | 7 | https://seqll.com | |
| 603658.SS | AUTOBIO DIAGNOSTICS CO LTD | Zhengzhou | China | CNY | SHH | -0.01 | 18.10 | 5031 | https://www.autobio.com.cn |
| 300676.SZ | BGI GENOMICS CO LT | Shenzhen | China | CNY | SHZ | 0.58 | 11.12 | https://www.bgi.com | |
| 300396.SZ | DIRUI INDUSTRIAL C | Changchun | China | CNY | SHZ | 0.50 | 17.02 | 1609 | https://www.dirui.com.cn |
| 2359.HK | WUXI APPTEC | Shanghai | China | HKD | HKG | 0.71 | 35.87 | 39716 | https://www.wuxiapptec.com |
| GTG.AX | GENE TECH FPO | Fitzroy | Australia | AUD | ASX | 1.16 | -2.76 | 18 | https://www.gtglabs.com |
| HLS.AX | HEALIUS FPO | St Leonards | Australia | AUD | ASX | 1.09 | 6.92 | 11000 | https://www.healius.com.au |
| GV.PA | GENOMIC VISION | Bagneux | France | EUR | PAR | 0.00 | -0.64 | 33 | https://www.genomicvision.com |
| EXAS | Exact Sciences Corporation | Madison | United States | USD | NCM | 1.31 | -18.12 | 6420 | https://www.exactsciences.com |
| SHC | Sotera Health Company | Broadview Heights | United States | USD | NMS | 6.92 | 3000 | https://soterahealth.com | |
| NEOG | Neogen Corporation | Lansing | United States | USD | NMS | 0.62 | 19.61 | https://www.neogen.com | |
| DHR | Danaher Corporation | Washington | United States | USD | NYQ | 0.83 | 20.95 | 78000 | https://www.danaher.com |
| FLRY3.SA | FLEURY ON NM | São Paulo | Brazil | BRL | SAO | 0.91 | 8.57 | 16700 | https://ri.fleury.com.br |
| NEO | NeoGenomics, Inc. | Fort Myers | United States | USD | NCM | 0.94 | -13.99 | 2000 | https://www.neogenomics.com |
| 7707.T | PRECISION SYSTEM SCIENCE CO | Matsudo | Japan | JPY | JPX | 0.95 | 19.95 | 187 | https://www.pss.co.jp |
| ILMN | Illumina, Inc. | San Diego | United States | USD | NMS | 1.10 | 37.61 | 9800 | https://www.illumina.com |
| A | Agilent Technologies, Inc. | Santa Clara | United States | USD | NYQ | 1.04 | 21.33 | 17000 | https://www.agilent.com |
| ACL.AX | AUCLINICAL FPO | Clayton | Australia | AUD | ASX | 4.80 | https://www.clinicallabs.com.au | ||
| 505.SI | $ AsiaMedic | Singapore | Singapore | SGD | SES | 1.55 | 16.49 | https://www.asiamedic.com.sg | |
| IBX.AX | IMAGIONBIO FPO | San Diego | United States | AUD | ASX | 3.00 | -2.86 | https://imagionbiosystems.com | |
| LNTH | Lantheus Holdings, Inc. | North Billerica | United States | USD | NGM | 0.75 | 49.39 | 612 | https://www.lantheus.com |
| TMO | Thermo Fisher Scientific Inc | Waltham | United States | USD | NYQ | 0.82 | 20.63 | 130000 | https://www.thermofisher.com |
| NTRA | Natera, Inc. | San Carlos | United States | USD | NMS | 1.36 | -7.15 | 2670 | https://www.natera.com |
| IQV | IQVIA Holdings, Inc. | Durham | United States | USD | NYQ | 1.38 | 18.12 | 85000 | https://www.iqvia.com |
| 1H3.SI | $ Clearbridge | Singapore | Singapore | SGD | SES | 1.16 | 36.58 | 172 | https://www.clearbridgehealth.com |
| SHL.AX | SONIC HLTH FPO | Sydney | Australia | AUD | ASX | 0.49 | 8.19 | 38000 | https://www.sonichealthcare.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend. - Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend. - Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction. - Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend. - Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce. - Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk. - Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.